ASHLEY TILLER: Open Payments
NPI 1700451499 · LORIS, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,022 in 50 payments from 23 companies in 2025. Trend: 2023 $269 · 2024 $715 · 2025 $1,022
Food & beverage: $1,022
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 4 | $123 |
| Otsuka America Pharmaceutical, Inc. | 5 | $120 |
| ANI Pharmaceuticals, Inc. | 4 | $113 |
| AstraZeneca Pharmaceuticals LP | 6 | $96 |
| Amgen Inc. | 4 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Novo Nordisk Inc | 2 | $44 |
| ABBVIE INC. | 2 | $44 |
| Ardelyx, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $37 |
Products named: TARPEYO, PURIFIED CORTROPHIN GEL, JYNARQUE, CAPLYTA, AIRSUPRA, Ozempic, VRAYLAR, OTEZLA.
Industry payments across SC — which companies pay providers there.
